Exploratory Grants for Behavioral Research in Cancer Control (R21)
Posted by National Institutes of Health
Opportunity snapshot. This Grants.gov announcement — Exploratory Grants for Behavioral Research in Cancer Control (R21) — is cataloged under number PA-06-351 and tied to CFDA assistance listing 93.399, posted by National Institutes of Health. Grants.gov currently shows the opportunity as open, first posted on April 12, 2006 and last updated on December 5, 2008. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Up to $200,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity is open, but Grants.gov has not published a hard closing date — check the official listing for the current deadline and any posted amendments. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully — federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed — it helps clarify scope and scoring priorities.
Award Range
Up to $200,000
Close Date
Not specified
Multiple Receipt Dates - See Link to Full Announcement for details.
Posted
April 12, 2006
Instrument
Grant
Description
The purpose of this funding opportunity announcement (FOA) is to encourage exploratory and developmental research projects (R21) grant applications in the cancer control research continuum (i.e., primary prevention to end of life care) from investigators representing a range of behavioral and social science disciplines. With this FOA, the Division of Cancer Control and Population Sciences of the National Cancer Institute (NCI) invites the submission of R21 grant applications that describe research projects that will utilize developmental and exploratory approaches to primary and secondary cancer prevention and control. Research areas may include: cancer health and risk communication; enhancing cancer survivorship; promoting healthy diet and physical activity; prevention and control of tobacco use; interaction between psychosocial and biological mechanisms; cancer screening behaviors; and palliative and end-of-life care.-Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications; therefore, the anticipated number of awards is not known. -This FOA utilizes the NIH Exploratory/Developmental (R21) grant mechanism. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. -The total project period for an application submitted in response to this funding opportunity may not exceed 2 years. Direct costs are limited to $275,000 over an R21 2-year period, with no more than $200,000 in direct costs allowed in any single year. -Eligible organizations include: for-profit organizations; non-profit organizations; public or private institutions, such as universities, colleges, hospitals and laboratories; units of State governments; units of local governments; eligible institutions of the Federal government; domestic institutions; foreign institutions; faith-based or community-based organizations; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); and Indian/Native American Tribally Designated Organization. - Eligible Project Directors/Principal Investigators (PDs/PIs) include any individuals from the applicant institutions who have the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -Applicants may submit more than one application, provided each application is scientifically distinct.
Eligibility
00;01;02;04;05;06;07;08;11;12;13;20;22;25
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Cancer Control
Centers for Disease Control and Prevention
Agency Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from National Institutes of Health
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology — how this data is sourced, computed, and verified.
Related
| Publisher | Kiznis Studio |
| Sources | Public official public datasets |